elbasvir 50 MG grazoprevir 100 MG Oral Tablet Zepatier

1 INDICATIONS AND USAGE ZEPATIER ® is indicated for the treatment of chronic hepatitis C virus (HCV) genotype 1 or 4 infection in adult and pediatric patients 12 years of age and older or weighing at least 30 kg. ZEPATIER is indicated for use with ribavirin in certain patient populations [see Dosage and Administration (2.2) ] . ZEPATIER is a fixed-dose combination product containing elbasvir, a hepatitis C virus (HCV) NS5A inhibitor, and grazoprevir, an HCV NS3/4A protease inhibitor, and is indicated for treatment of chronic HCV genotype 1 or 4 infection in adult and pediatric patients 12 years of age and older or weighing at least 30 kg. ZEPATIER is indicated for use with ribavirin in certain patient populations. ( 1 )

Merck Sharp & Dohme Corp.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] pain` `[4] nausea` `[5] headache` `[6] off label use` `[7] toxicity to various agents` `[8] dyspnoea` `[9] arthralgia` `[10] vomiting`

10 months ago

OVAL BROWN 770

16 HOW SUPPLIED/STORAGE AND HANDLING Each ZEPATIER tablet contains 50 mg elbasvir and 100 mg grazoprevir, is beige, oval-shaped, film-coated, debossed with "770" on one side and plain on the other. The tablets are packaged into a carton (NDC 0006-3074-02) containing two (2) 14-count child-resistant dose packs for a total of 28 tablets. Store ZEPATIER in the original blister package until use to protect from moisture. Store ZEPATIER at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (between 59°F to 86°F) [see USP Controlled Room Temperature].

More pills like OVAL 770

Related Pills

elbasvir 50 MG grazoprevir 100 MG Oral Tablet Zepatier

Merck Sharp & Dohme Corp.

Olanzapine olanzapine 10 MG Oral Tablet

Teva Pharmaceuticals USA Inc

levocetirizine dihydrochloride 5 MG Oral Tablet

Teva Pharmaceuticals USA, Inc.

diphenoxylate hydrochloride and atropine sulfate tablet

lannett company, inc.

flucytosine capsule

american health packaging

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site